Fresenius Shares 5 Ways Artificial intelligence is Helping Dialysis Care
Learn how AI is reducing short and long-term PD interruptions, risk of access failure, and hospitalizations; informing a device to monitor relative blood volume; and more.
Read the full article » | Posted 08-21-2025
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026